https://www.selleckchem.com/TGF-beta.html Therefore, targeting these polymerases presents a novel therapeutic strategy to combat chemoresistance. Mounting evidence suggests that inhibition of Pol η may have multiple impacts on cancer therapy such as sensitizing cancer cells to chemotherapeutics, suppressing drug-induced mutagenesis, and inhibiting the development of secondary tumors. Herein, we provide a general introduction of Pol η and its clinical implications in blocking acquired drug resistance. In addition; this review addresses the existing gaps and challenges of Pol η mediated TLS mechanisms in human cells. A better understanding of the Pol η mediated TLS mechanism will not merely establish it as a potential pharmacological target but also open possibilities to identify novel drug targets for future therapy. Thirty-five university nursing students in Japan participated in this randomized controlled trial. The revised process recording referred to self-compassion. Both the control and intervention groups completed the self-compassion scale (SCS) pre- and post-intervention. A repeated two-way analysis of variance examined the interaction effect of time × group on the SCS subscales. A significant interaction effect was observed only for mindfulness; the score only increased in the intervention group. The revised process recording might facilitate self-compassion, making it appropriate for nursing education. The revised process recording might facilitate self-compassion, making it appropriate for nursing education.Morphine, a mu-opioid receptor (MOR) agonist, has been extensively used to treat advanced cancer pain. In particular, in patients with cancer metastasis, both morphine and anticancer drugs are given simultaneously. However, evidence showed that morphine might be a risk factor in promoting the tumor's malignant potential. In this study, we report that treatment with morphine could activate MOR and lead to the promotion of proliferation, migration, and i